185 related articles for article (PubMed ID: 35317849)
21. [Exploratory screening of potential pan-cancer biomarkers based on The Cancer Genome Atlas database].
Zhou C; Ma X; Xing YK; Li LD; Chen J; Yao BY; Fu JL; Zhao P
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 53(3):602-607. PubMed ID: 34145869
[TBL] [Abstract][Full Text] [Related]
22. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract][Full Text] [Related]
23. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
Yang Q; Li K; Li X; Liu J
Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
[No Abstract] [Full Text] [Related]
24. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
[TBL] [Abstract][Full Text] [Related]
25. Identification of core genes and potential molecular mechanisms in breast cancer using bioinformatics analysis.
Liu F; Wu Y; Mi Y; Gu L; Sang M; Geng C
Pathol Res Pract; 2019 Jul; 215(7):152436. PubMed ID: 31076281
[TBL] [Abstract][Full Text] [Related]
26. Pan-Cancer Analyses Reveal Long Intergenic Non-Coding RNAs Relevant to Tumor Diagnosis, Subtyping and Prognosis.
Ching T; Peplowska K; Huang S; Zhu X; Shen Y; Molnar J; Yu H; Tiirikainen M; Fogelgren B; Fan R; Garmire LX
EBioMedicine; 2016 May; 7():62-72. PubMed ID: 27322459
[TBL] [Abstract][Full Text] [Related]
27. Identification of Candidate Genes Associated with Breast Cancer Prognosis.
Xu YH; Deng JL; Wang LP; Zhang HB; Tang L; Huang Y; Tang J; Wang SM; Wang G
DNA Cell Biol; 2020 Jul; 39(7):1205-1227. PubMed ID: 32456464
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells.
Zhang Y; He RQ; Dang YW; Zhang XL; Wang X; Huang SN; Huang WT; Jiang MT; Gan XN; Xie Y; Li P; Luo DZ; Chen G; Gan TQ
Cancer Cell Int; 2016; 16():89. PubMed ID: 27980454
[TBL] [Abstract][Full Text] [Related]
29. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
30. Systematic pathway enrichment analysis of a genome-wide association study on breast cancer survival reveals an influence of genes involved in cell adhesion and calcium signaling on the patients' clinical outcome.
Woltmann A; Chen B; Lascorz J; Johansson R; Eyfjörd JE; Hamann U; Manjer J; Enquist-Olsson K; Henriksson R; Herms S; Hoffmann P; Hemminki K; Lenner P; Försti A
PLoS One; 2014; 9(6):e98229. PubMed ID: 24886783
[TBL] [Abstract][Full Text] [Related]
31. Identification of differentially expressed metastatic genes and their signatures to predict the overall survival of uveal melanoma patients by bioinformatics analysis.
Zhao DD; Zhao X; Li WT
Int J Ophthalmol; 2020; 13(7):1046-1053. PubMed ID: 32685390
[TBL] [Abstract][Full Text] [Related]
32. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
Ni KW; Sun GZ
Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
[TBL] [Abstract][Full Text] [Related]
33. The Clinicopathological Significance and Correlative Signaling Pathways of an Autophagy-Related Gene, Ambra1, in Breast Cancer: a Study of 25 Microarray RNA-Seq Datasets and in-House Gene Silencing.
He RQ; Xiong DD; Ma J; Hu XH; Chen G; Sun WL
Cell Physiol Biochem; 2018; 51(3):1027-1040. PubMed ID: 30476925
[TBL] [Abstract][Full Text] [Related]
34. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Wu J; Lv Q; Huang H; Zhu M; Meng D
Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
[No Abstract] [Full Text] [Related]
35. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849
[TBL] [Abstract][Full Text] [Related]
36. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
Deng JL; Xu YH; Wang G
Front Genet; 2019; 10():695. PubMed ID: 31428132
[No Abstract] [Full Text] [Related]
37. Transcriptomic Analysis of Breast Cancer Patients Sensitive and Resistant to Chemotherapy: Looking for Overall Survival and Drug Resistance Biomarkers.
Barrón-Gallardo CA; Garcia-Chagollán M; Morán-Mendoza AJ; Delgadillo-Cristerna R; Martínez-Silva MG; Aguilar-Lemarroy A; Jave-Suárez LF
Technol Cancer Res Treat; 2022; 21():15330338211068965. PubMed ID: 34981997
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.
Gao ZY; Su LC; Wu QC; Sheng JE; Wang YL; Dai YF; Chen AP; He SS; Huang X; Yan GQ
Clin Rheumatol; 2022 Feb; 41(2):437-452. PubMed ID: 34553293
[TBL] [Abstract][Full Text] [Related]
39. Combined Analysis of ChIP Sequencing and Gene Expression Dataset in Breast Cancer.
Liu P; Jiang W; Zhou S; Gao J; Zhang H
Pathol Oncol Res; 2017 Apr; 23(2):361-368. PubMed ID: 27654269
[TBL] [Abstract][Full Text] [Related]
40. Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer.
Merry CR; McMahon S; Thompson CL; Miskimen KL; Harris LN; Khalil AM
Breast Cancer Res Treat; 2015 Apr; 150(2):321-34. PubMed ID: 25749757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]